CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-27 | Russell Alan J Chief Scientific Officer | Sale | −11,594 | $17.98 | $208K | 205,571 |
| 2021-09-27 | Russell Alan J Chief Scientific Officer | Sale | −17 | $18.48 | $314 | 205,554 |
| 2021-09-24 | Russell Alan J Chief Scientific Officer | Sale | −20,100 | $18.16 | $365K | 217,165 |
| 2021-09-23 | Russell Alan J Chief Scientific Officer | Sale | −21,763 | $18.34 | $399K | 242,337 |
| 2021-09-23 | Russell Alan J Chief Scientific Officer | Sale | −5,072 | $19.42 | $98K | 237,265 |
| 2021-08-17 | Russell Alan J Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2021-08-17 | MOORE JOHN R General Counsel | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2021-08-17 | Donovan Joanne M. CMO | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2021-08-17 | Derakhshan Behrad Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2021-08-17 | Carruthers R Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2021-08-17 | KOCH KEVIN President and CEO | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2021-04-30 | Donovan Joanne M. CMO | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2021-03-30 | ROOT JONATHAN D Director | Conversion | +3,473,543 | 3,473,543 | ||
| 2021-03-30 | ROOT JONATHAN D Director | Purchase | +15,625 | $16.00 | $250K | 15,625 |
| 2021-03-30 | ROOT JONATHAN D Director | Conversion · Series B-1 Preferred Stock | −1,651,607 | 0 | ||
| 2021-03-30 | ROOT JONATHAN D Director | Conversion · Series B-2 Preferred Stock | −1,366,707 | 0 | ||
| 2021-03-30 | ROOT JONATHAN D Director | Conversion · Series C Preferred Stock | −455,229 | 0 | ||
| 2021-03-30 | Thompson Peter A. Director | Conversion | +12,730,036 | 13,046,956 | ||
| 2021-03-30 | Thompson Peter A. Director | Conversion | +272,724 | 272,724 | ||
| 2021-03-30 | Thompson Peter A. Director | Purchase | +46,875 | $16.00 | $750K | 319,599 |
Page 24 of 26 · 509 trades